Researchers at the University of Massachusetts Medical School are trying to develop an alternative way to prevent Lyme disease infection: a drug that could be administered to those at risk annually, just before tick season, the Boston Globe reported.
Though it sounds like the flu shot, the drug is not a vaccine, which activates the immune system against an invader. Instead, it is a pre-exposure prophylaxis, a molecule ready to kill bacteria immediately, similar to pills taken to ward off malaria when traveling abroad. “You take the medicine before you’re going to be exposed,” says lead researcher Mark Klempner, executive vice chancellor at MassBiologics, the nonprofit drug research and manufacturing arm of UMass.
Klempner and colleagues presented positive results from mouse studies at two infectious disease conferences last month, but the details have yet to be reviewed by other scientists or published.
Click here to read the entire article
Source: Boston Globe
Latest from Pest Control Technology
- TAP Showcases Unique EPA-Registered Insulation Solution
- Atticus' Growing Pest Management Product Portfolio
- Bobby Jenkins Named the 2025 Crown Lifetime Achievement Award Recipient
- Abell Pest Control Marks Five Years of ‘12 Days of Giving’
- Built-by-Owner Home? Look for Surprises
- The Pest Rangers Acquires O.C.E. Pest & Termite Control
- The Professional Pest Management Alliance Expands Investor Network
- Big Blue Bug Solutions’ Holiday Lighting Event Sets New Viewership Record
